Literature DB >> 3334167

The influence of drugs on nasal ciliary movement.

W A Hermens1, F W Merkus.   

Abstract

Drugs in nasal preparations, for local use as well as for systemic use, should not interfere with the self-cleaning capacity of the nose, effectuated by the ciliary epithelium. Many drugs and additives, however, have a negative effect on nasal ciliary function. Examples of ciliotoxic agents are lipophilic and mercuric preservatives, local anesthetics, antihistamines, propranolol, and absorption enhancers such as the bile salts. Cholinergic drugs and beta-adrenergic drugs exert a ciliostimulatory effect. It is the purpose of this review to summarize the present knowledge of ciliotoxicity of drugs and additives and to give recommendations for the use of ciliofriendly drugs in nasal preparations.

Entities:  

Mesh:

Year:  1987        PMID: 3334167     DOI: 10.1023/a:1016463118748

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  46 in total

Review 1.  The immotile-cilia syndrome and other ciliary diseases.

Authors:  B A Afzelius
Journal:  Int Rev Exp Pathol       Date:  1979

2.  The in vitro and in vivo effect of a new non-halogenated corticosteroid - budesonide - aerosol on human ciliary epithelial function.

Authors:  G S Duchateau; J Zuidema; F W Merkus
Journal:  Allergy       Date:  1986-05       Impact factor: 13.146

3.  A method for standardized studies of mucociliary activity.

Authors:  U Mercke; C H Håkansson; N G Toremalm
Journal:  Acta Otolaryngol       Date:  1974 Jul-Aug       Impact factor: 1.494

4.  [Effect of bronchospasmolytics on ciliary beat frequency in vitro].

Authors:  N Konietzko; R Kasparek; U Kellner; J Petro
Journal:  Prax Klin Pneumol       Date:  1983-10

5.  Effects of penicillins in vitro on mucociliary activity of rabbit trachea.

Authors:  N G Toremalm; K Josefsson; K Klementsson; I Lagergren
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-08

6.  The study of ciliary frequencies with an optical spectrum analysis system.

Authors:  J R Kennedy; K E Duckett
Journal:  Exp Cell Res       Date:  1981-09       Impact factor: 3.905

7.  Nasal absorption of propranolol in humans.

Authors:  A Hussain; T Foster; S Hirai; T Kashihara; R Batenhorst; M Jones
Journal:  J Pharm Sci       Date:  1980-10       Impact factor: 3.534

8.  Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways.

Authors:  J Rutland; W M Griffin; P J Cole
Journal:  Am Rev Respir Dis       Date:  1982-01

9.  The effects of nasal drops on the ciliary beat frequency of chicken embryo tracheas.

Authors:  H J van de Donk; J Zuidema; F W Merkus
Journal:  Rhinology       Date:  1981-12       Impact factor: 3.681

10.  Growth and Pathogenesis of Mycoplasma mycoides var. capri in Chicken Embryo Tracheal Organ Cultures.

Authors:  J D Cherry; D Taylor-Robinson
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

View more
  16 in total

Review 1.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Delivery of hormones: some new concepts.

Authors:  W A Hermens
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

Review 3.  Improvement of drug absorption through enhancers.

Authors:  A G de Boer; E J van Hoogdalem; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  Transport of peptide and protein drugs across biological membranes.

Authors:  J C Verhoef; H E Boddé; A G de Boer; J A Bouwstra; H E Junginger; F W Merkus; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 5.  The nasal mucociliary clearance: relevance to nasal drug delivery.

Authors:  N G Schipper; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

6.  Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.

Authors:  K Morimoto; H Yamaguchi; Y Iwakura; M Miyazaki; E Nakatani; T Iwamoto; Y Ohashi; Y Nakai
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

Review 7.  Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective.

Authors:  A E Pontiroli; A Calderara; G Pozza
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

8.  Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.

Authors:  W A Hermens; P M Hooymans; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

9.  Influence of azelastine and some selected drugs on mucociliary clearance.

Authors:  U Achterrath-Tuckermann; V Saano; E Minker; F Stroman; I Arny; S Joki; J Nuutinen; I Szelenyi
Journal:  Lung       Date:  1992       Impact factor: 2.584

10.  Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.

Authors:  W A Hermens; M J Deurloo; S G Romeyn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.